全球神經刺激設備市場規模、佔有率、成長分析，依類型（植入式裝置和非植入式裝置）、依應用（疼痛管理和帕金森氏症）- 2024-2031 年產業預測

Global Neurostimulation Devices Market Size, Share, Growth Analysis, By Type(Implantable Devices and Non-Implantable Devices), By Application(Pain Management and Parkinson's Disease) - Industry Forecast 2024-2031

出版日期: 2024年03月27日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球神經刺激設備市場規模預估為53億美元，預計將從2023年的59.8億美元成長到2031年的156.7億美元，預測期間（2024-2031年）複合年成長率為12.80%。

在多種因素的推動下，神經刺激設備市場正在經歷強勁成長。其中包括人口老化、先進產品的引入、對附加治療的需求不斷增加以及偏頭痛和癲癇等慢性疾病的增加。此外，這些疾病領域的醫療需求未被滿足，加上神經系統疾病和生活方式相關疾病的流行，都有助於市場擴張。用於研發的外部資金以及對微創手術的需求進一步推動了這一成長。根據美國神經病學會的數據，中風和阿茲海默症是美國最主要的死亡原因之一，而帕金森氏症每年影響大量美國人。隨著神經系統疾病發病率的上升，對神經刺激設備的需求預計將持續增加。製造商正在大力投資研發，重點關注植入式神經刺激設備等先進產品，預計這些產品將推動市場成長。此外，神經刺激裝置植入的侵入性較小，可縮短住院時間和加速復原時間，並有望為市場開闢新的成長途徑。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名企業比較
2021 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率（%），2021年

主要公司簡介

Medtronic (Ireland)
Abbott Laboratories (US)
Boston Scientific Corporation (US)
LivaNova PLC (UK)
Nevro Corp. (US)
NeuroPace, Inc. (US)
Synapse Biomedical Inc. (US)
Neuronetics, Inc. (US)
Cyberonics, Inc. (US)
St. Jude Medical, Inc. (US)
Cogentix Medical, Inc. (US)
NDI Medical LLC (US)
Stimwave Technologies (US)
BioControl Medical (Israel)
EndoStim (US)
EnteroMedics (US)
Aleva Neurotherapeutics (Switzerland)
SPR Therapeutics (US)
electroCore, Inc. (US)
Soterix Medical Inc. (US)

簡介目錄

Product Code: SQMIG35B2087

Global Neurostimulation Devices Market size was valued at USD 5.3 Billion in 2022 and is poised to grow from USD 5.98 Billion in 2023 to USD 15.67 Billion by 2031, at a CAGR of 12.80% during the forecast period (2024-2031).

The neurostimulation device market is experiencing robust growth driven by various factors. These include an aging population, the introduction of advanced products, increasing demand for add-on therapy, and a rise in chronic diseases like migraine and epilepsy. Additionally, high unmet medical needs in these disease segments, coupled with the prevalence of neurological disorders and lifestyle-related diseases, contribute to market expansion. External funding for research and development, along with the demand for minimally invasive surgeries, further fuel this growth. According to the American Academy of Neurology, stroke and Alzheimer's rank among the leading causes of death in the United States, while Parkinson's disease affects a significant number of Americans annually. With the rising incidence of neurological diseases, the demand for neurostimulation devices is projected to escalate. Manufacturers are heavily investing in research and development, focusing on advanced products like implantable neurostimulation devices, which are anticipated to propel market growth. Moreover, the less invasive nature of neurostimulation device implantation, leading to shorter hospital stays and quicker recovery times, is poised to open up new growth avenues for the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurostimulation Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurostimulation Devices Market Segmental Analysis

Global Neurostimulation Devices market is segmented by type, Application, and region. Based on type, the market can be segmented into implantable devices and non-implantable devices. Based on Application, the market is segmented into pain management, and Parkinson's disease. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Neurostimulation Devices Market

The escalating occurrence of neurological disorders globally serves as a primary catalyst for the growth of the neurostimulation devices market. With neurological disorders, including Parkinson's disease, epilepsy, and chronic pain, imposing a substantial burden of disease worldwide, millions of individuals are affected, as highlighted by the World Health Organization. This burgeoning prevalence underscores the escalating demand for neurostimulation devices as a viable treatment solution. Consequently, manufacturers are channeling investments into research and development endeavors aimed at innovating advanced neurostimulation devices, thus contributing to the anticipated expansion of the market.

Restraints in the Global Neurostimulation Devices Market

Despite the increasing need for neurostimulation devices, their steep prices continue to pose a significant obstacle to market expansion. The high cost places a considerable financial strain on patients, particularly those residing in low- and middle-income nations. Moreover, the scarcity of proficient healthcare practitioners and the restricted accessibility of these devices in certain areas further stifle market progression. Additionally, the potential hazards linked with device implantation, including infection and malfunction, could also hinder market advancement.

Market Trends of the Global Neurostimulation Devices Market

A prominent trend in the neurostimulation devices market is the advancement of minimally invasive and non-invasive technologies, which are increasingly favored for their benefits over conventional surgical methods such as decreased pain, shorter hospital stays, and quicker recovery. Furthermore, the emergence of wireless and implantable devices is contributing to market expansion by providing patients with enhanced comfort and convenience without the need for external wires or bulky devices. This shift towards less invasive neurostimulation technologies is projected to persist, driving further market growth in the foreseeable future.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Neurostimulation Devices Market by Type

Market Overview
Implantable Devices and Non-Implantable Devices

Global Neurostimulation Devices Market by Application

Market Overview
Pain Management and Parkinson's Disease

Global Neurostimulation Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (U.K.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroPace, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synapse Biomedical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuronetics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyberonics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
St. Jude Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cogentix Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NDI Medical LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stimwave Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioControl Medical (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EndoStim (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EnteroMedics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aleva Neurotherapeutics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SPR Therapeutics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
electroCore, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Soterix Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments